Cancer cachexia: a multifactoral disease that needs a multimodal approach;
Stubbins, R, Bernicker, EH & Quigley, EM 2020, Current opinion in gastroenterology, vol. 36, no. 2, pp. 141-146.

Comparison of outcomes between metaplastic and triple-negative breast cancer patients;
Polamraju, P, Haque, WM, Cao, K, Verma, V, Schwartz, M, Klimberg, VS, Hatch, S, Niravath, PA, Butler, EB & Teh, BS 2020, Breast, vol. 49, pp. 8-16.

Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis;
Black, CJ, Yuan, Y, Selinger, CP, Camilleri, M, Quigley, EM, Moayyedi, P & Ford, AC 2020, The Lancet Gastroenterology and Hepatology, vol. 5, no. 2, pp. 117-131.

Polyethylene glycol-based laxatives for chronic constipation – Authors' reply;
Luthra, P, Camilleri, M, Burr, NE, Quigley, EM, Black, CJ & Ford, AC 2020, The Lancet Gastroenterology and Hepatology, vol. 5, no. 2, pp. 110-111.

The effect of angioplasty of single arteriovenous fistula-associated stenosis on arteriovenous fistula blood flow rate;
Nassar, GM, Beathard, G, Nguyen, DT & Graviss, EA 2020, The journal of vascular access, pp. 1129729819901223.

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer;
Yomtoubian, S, Lee, SB, Verma, A, Izzo, F, Markowitz, G, Choi, H, Cerchietti, L, Vahdat, L, Brown, KA, Andreopoulou, E, Elemento, O, Chang, JC, Inghirami, G, Gao, D, Ryu, S & Mittal, V 2020, Cell Reports, vol. 30, no. 3, pp. 755-770.e6.

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer;
Goldstein, LJ, Perez, RP, Yardley, D, Han, LK, Reuben, JM, Gao, H, McCanna, S, Butler, B, Ruffini, PA, Liu, Y, Rosato, RR & Chang, JC 2020, Breast Cancer Research, vol. 22, no. 1, 4.

Comparison of Levothyroxine Dosing in Patients with and without Heart Failure;
Yang, T, Ruegger, M, Colavecchia, AC, Sadhu, A, Patham, B & Tatara, A 2020, Endocrine Research, vol. 45, no. 1, pp. 50-57.

A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer;
He, T, Puppala, M, Ezeana, CF, Huang, Y-S, Chou, P-H, Yu, X, Chen, S, Wang, L, Yin, Z, Danforth, RL, Ensor, J, Chang, J, Patel, T & Wong, STC 2020, JCO Clinical Cancer Informatics, vol. 3, pp. 1-12.
Live Chat Available